Accellacare Espana S.L.

At Accellacare Espana S.L. in Alcobendas, Spain, rheumatology research is focused on inflammatory conditions such as psoriatic arthritis, rheumatoid arthritis, and systemic lupus erythematosus. These studies are mainly designed to evaluate new treatments that may better control disease activity and improve day-to-day outcomes for people living with chronic immune-mediated illness.

• Psoriatic arthritis and related inflammatory joint disease
• Rheumatoid arthritis and systemic lupus erythematosus
• Testing therapies that may reduce inflammation and improve symptom control

The site’s work in this area reflects a strong emphasis on finding more effective options for patients whose symptoms remain difficult to manage with standard care.

Clinical trials in musculoskeletal diseases at this site include studies of chronic non-specific low back pain, gout, and psoriatic arthritis. The research is aimed at improving pain relief, lowering uric acid levels, and assessing whether new therapies can provide better long-term control of joint and spine-related conditions.

• Chronic non-specific low back pain
• Hyperuricemia associated with gout
• Evaluating treatments for pain reduction and metabolic control

These studies support efforts to expand treatment choices for people with persistent musculoskeletal symptoms and inflammatory joint disorders.

Research in nervous system diseases includes trials for agitation in dementia of the Alzheimer’s type. The goal is to assess whether investigational therapies can help manage behavioral symptoms more effectively while maintaining safety and tolerability for older adults and their caregivers.

• Agitation in dementia of the Alzheimer’s type
• Evaluating options to improve behavioral symptom management
• Supporting safer care for patients with cognitive decline

This area shows the site’s broader interest in conditions beyond rheumatology, with a focus on practical symptom relief in complex neurological illness.

Within respiratory tract diseases, the site is involved in studies of refractory chronic cough and unexplained chronic cough. These trials are designed to test new approaches that may reduce cough frequency and improve quality of life for people whose symptoms have not responded well to usual care.

• Refractory chronic cough
• Unexplained chronic cough
• Testing therapies aimed at lowering cough burden and improving daily comfort

By addressing persistent cough conditions, the research contributes to a field where effective treatment options are still limited.

Trials in skin and connective tissue diseases at Accellacare Espana S.L. include studies of nummular dermatitis and inflammatory skin conditions linked to psoriatic arthritis. The research is focused on evaluating new therapies that may better control skin inflammation, reduce flare severity, and improve overall disease management.

• Nummular dermatitis
• Psoriatic arthritis with skin involvement
• Assessing treatments for inflammation, symptom relief, and better skin health

These studies highlight the site’s involvement in immune-related skin research alongside its core rheumatology portfolio.